CAR-T Therapy for Hematological Cancer and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 CAR-T Therapy for Hematological Cancer Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global CAR-T Therapy for Hematological Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Therapy for Hematological Cancer Overall Market Size
2.1 Global CAR-T Therapy for Hematological Cancer Market Size: 2023 VS 2030
2.2 Global CAR-T Therapy for Hematological Cancer Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Therapy for Hematological Cancer Players in Global Market
3.2 Top Global CAR-T Therapy for Hematological Cancer Companies Ranked by Revenue
3.3 Global CAR-T Therapy for Hematological Cancer Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Therapy for Hematological Cancer Companies in Global Market, by Revenue in 2023
3.5 Global Companies CAR-T Therapy for Hematological Cancer Product Type
3.6 Tier 1, Tier 2, and Tier 3 CAR-T Therapy for Hematological Cancer Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Therapy for Hematological Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Therapy for Hematological Cancer Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Market Size Markets, 2023 & 2030
4.1.2 Target: CD19
4.1.3 Target: BCMA
4.1.4 Others
4.2 Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue & Forecasts
4.2.1 Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue, 2019-2024
4.2.2 Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue, 2025-2030
4.2.3 Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Market Size, 2023 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.1.4 Leukemia
5.2 Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue & Forecasts
5.2.1 Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue, 2019-2024
5.2.2 Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue, 2025-2030
5.2.3 Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global CAR-T Therapy for Hematological Cancer Market Size, 2023 & 2030
6.2 By Region - Global CAR-T Therapy for Hematological Cancer Revenue & Forecasts
6.2.1 By Region - Global CAR-T Therapy for Hematological Cancer Revenue, 2019-2024
6.2.2 By Region - Global CAR-T Therapy for Hematological Cancer Revenue, 2025-2030
6.2.3 By Region - Global CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America CAR-T Therapy for Hematological Cancer Revenue, 2019-2030
6.3.2 United States CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.3.3 Canada CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.3.4 Mexico CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe CAR-T Therapy for Hematological Cancer Revenue, 2019-2030
6.4.2 Germany CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4.3 France CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4.4 U.K. CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4.5 Italy CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4.6 Russia CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4.7 Nordic Countries CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.4.8 Benelux CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia CAR-T Therapy for Hematological Cancer Revenue, 2019-2030
6.5.2 China CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.5.3 Japan CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.5.4 South Korea CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.5.5 Southeast Asia CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.5.6 India CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America CAR-T Therapy for Hematological Cancer Revenue, 2019-2030
6.6.2 Brazil CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.6.3 Argentina CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Therapy for Hematological Cancer Revenue, 2019-2030
6.7.2 Turkey CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.7.3 Israel CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.7.4 Saudi Arabia CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
6.7.5 UAE CAR-T Therapy for Hematological Cancer Market Size, 2019-2030
7 Companies Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR-T Therapy for Hematological Cancer Major Product Offerings
7.1.4 Novartis CAR-T Therapy for Hematological Cancer Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR-T Therapy for Hematological Cancer Major Product Offerings
7.2.4 Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J&J
7.4.1 J&J Corporate Summary
7.4.2 J&J Business Overview
7.4.3 J&J CAR-T Therapy for Hematological Cancer Major Product Offerings
7.4.4 J&J CAR-T Therapy for Hematological Cancer Revenue in Global Market (2019-2024)
7.4.5 J&J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Corporate Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR-T Therapy for Hematological Cancer Major Product Offerings
7.5.4 JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue in Global Market (2019-2024)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Corporate Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR-T Therapy for Hematological Cancer Major Product Offerings
7.6.4 FOSUNKite CAR-T Therapy for Hematological Cancer Revenue in Global Market (2019-2024)
7.6.5 FOSUNKite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. CAR-T Therapy for Hematological Cancer Market Opportunities & Trends in Global Market
Table 2. CAR-T Therapy for Hematological Cancer Market Drivers in Global Market
Table 3. CAR-T Therapy for Hematological Cancer Market Restraints in Global Market
Table 4. Key Players of CAR-T Therapy for Hematological Cancer in Global Market
Table 5. Top CAR-T Therapy for Hematological Cancer Players in Global Market, Ranking by Revenue (2023)
Table 6. Global CAR-T Therapy for Hematological Cancer Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global CAR-T Therapy for Hematological Cancer Revenue Share by Companies, 2019-2024
Table 8. Global Companies CAR-T Therapy for Hematological Cancer Product Type
Table 9. List of Global Tier 1 CAR-T Therapy for Hematological Cancer Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Therapy for Hematological Cancer Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. Segmentation by Type � Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2023 & 2030
Table 12. Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue (US$, Mn), 2019-2024
Table 13. Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue (US$, Mn), 2025-2030
Table 14. Segmentation by Application� Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2023 & 2030
Table 15. Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 16. Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 17. By Region� Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 19. By Region - Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 20. By Country - North America CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Corporate Summary
Table 31. Novartis CAR-T Therapy for Hematological Cancer Product Offerings
Table 32. Novartis CAR-T Therapy for Hematological Cancer Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Corporate Summary
Table 35. Gilead Sciences CAR-T Therapy for Hematological Cancer Product Offerings
Table 36. Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue (US$, Mn) & (2019-2024)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Corporate Summary
Table 39. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Product Offerings
Table 40. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J&J Corporate Summary
Table 43. J&J CAR-T Therapy for Hematological Cancer Product Offerings
Table 44. J&J CAR-T Therapy for Hematological Cancer Revenue (US$, Mn) & (2019-2024)
Table 45. J&J Key News & Latest Developments
Table 46. JW Therapeutics Corporate Summary
Table 47. JW Therapeutics CAR-T Therapy for Hematological Cancer Product Offerings
Table 48. JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue (US$, Mn) & (2019-2024)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Corporate Summary
Table 51. FOSUNKite CAR-T Therapy for Hematological Cancer Product Offerings
Table 52. FOSUNKite CAR-T Therapy for Hematological Cancer Revenue (US$, Mn) & (2019-2024)
Table 53. FOSUNKite Key News & Latest Developments
List of Figures
Figure 1. CAR-T Therapy for Hematological Cancer Product Picture
Figure 2. CAR-T Therapy for Hematological Cancer Segment by Type in 2023
Figure 3. CAR-T Therapy for Hematological Cancer Segment by Application in 2023
Figure 4. Global CAR-T Therapy for Hematological Cancer Market Overview: 2022
Figure 5. Key Caveats
Figure 6. Global CAR-T Therapy for Hematological Cancer Market Size: 2023 VS 2030 (US$, Mn)
Figure 7. Global CAR-T Therapy for Hematological Cancer Revenue: 2019-2030 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by CAR-T Therapy for Hematological Cancer Revenue in 2023
Figure 9. Segmentation by Type � Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 10. Segmentation by Type - Global CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 11. Segmentation by Application � Global CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 12. Segmentation by Application - Global CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 13. By Region - Global CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 14. By Country - North America CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 15. United States CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 16. Canada CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 17. Mexico CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 18. By Country - Europe CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 19. Germany CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 20. France CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 21. U.K. CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 22. Italy CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 23. Russia CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 24. Nordic Countries CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 25. Benelux CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 26. By Region - Asia CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 27. China CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 28. Japan CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 29. South Korea CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 30. Southeast Asia CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 31. India CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 32. By Country - South America CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 33. Brazil CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 34. Argentina CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 35. By Country - Middle East & Africa CAR-T Therapy for Hematological Cancer Revenue Market Share, 2019-2030
Figure 36. Turkey CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 37. Israel CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 38. Saudi Arabia CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 39. UAE CAR-T Therapy for Hematological Cancer Revenue, (US$, Mn), 2019-2030
Figure 40. Novartis CAR-T Therapy for Hematological Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 41. Gilead Sciences CAR-T Therapy for Hematological Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bristol-Myers Squibb CAR-T Therapy for Hematological Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. J&J CAR-T Therapy for Hematological Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. JW Therapeutics CAR-T Therapy for Hematological Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. FOSUNKite CAR-T Therapy for Hematological Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
